BCL2 and cancer: Therefore, the significant increase of Bax/Bcl‐2, and the significant reduction in p‐AKT/AKT and TLR4/NF‐κB indicated that combined treatment with Abx and DSF/Cu2+ significantly attenuates inflammatory effects and promoted the apoptosis of cancer cells (Figure 3).